Skip to main navigation Skip to search Skip to main content

The urgent need for designing greener drugs

  • Tomas Brodin*
  • , Michael G. Bertram*
  • , Kathryn E. Arnold
  • , Alistair B.A. Boxall
  • , Bryan W. Brooks
  • , Daniel Cerveny
  • , Manuela Jörg
  • , Karen A. Kidd
  • , Unax Lertxundi
  • , Jake M. Martin
  • , Lauren T. May
  • , Erin S. McCallum
  • , Marcus Michelangeli
  • , Charles R. Tyler
  • , Bob B.M. Wong
  • , Klaus Kümmerer
  • , Gorka Orive*
  • *Corresponding author for this work

Research output: Journal contributionsComments / Debate / ReportsResearch

33 Citations (Scopus)

Abstract

The pervasive contamination of ecosystems with active pharmaceutical ingredients poses a serious threat to biodiversity, ecosystem services and public health. Urgent action is needed to design greener drugs that maintain efficacy but also minimize environmental impact.

Original languageEnglish
JournalNature Sustainability
Volume7
Issue number8
Pages (from-to)949-951
Number of pages3
ISSN2398-9629
DOIs
Publication statusPublished - 08.2024

Bibliographical note

Publisher Copyright:
© Springer Nature Limited 2024.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being
  2. SDG 7 - Affordable and Clean Energy
    SDG 7 Affordable and Clean Energy

Research areas and keywords

  • Chemistry
  • Drug regulation
  • environmental impact

ASJC Scopus Subject Areas

  • Ecology
  • Food Science
  • Urban Studies
  • Global and Planetary Change
  • Nature and Landscape Conservation
  • Geography, Planning and Development
  • Renewable Energy, Sustainability and the Environment
  • Management, Monitoring, Policy and Law

Fingerprint

Dive into the research topics of 'The urgent need for designing greener drugs'. Together they form a unique fingerprint.

Cite this